Target Name: LOC105369325
NCBI ID: G105369325
Review Report on LOC105369325 Target / Biomarker Content of Review Report on LOC105369325 Target / Biomarker
LOC105369325
Other Name(s): uncharacterized LOC105369325 | Uncharacterized LOC105369325, transcript variant X2 | LOC105369325 variant X2

LOC105369325: A Drug Target / Disease Biomarker

LOC105369325 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in the concentration of thermal energy in the cell.

LOC105369325 is of particular interest as a potential drug target because of its role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also a strong candidate for use as a biomarker for these diseases, as it can be easily measured and detected in the body.

One of the functions of LOC105369325 is to help the cell withstand the stress that can be caused by increased thermal energy. HSP proteins are known for their ability to take on a variety of conformations that can help them to interact with various molecules and to protect the cell from the effects of stress.

In addition to its role in stress response, LOC105369325 is also involved in the regulation of inflammation. It has been shown to play a key role in the production of inflammatory cytokines, which are proteins that are involved in the recruitment of immune cells to the site of an injury or infection.

LOC105369325 is also of interest as a potential drug target because of its role in the development of neurodegenerative diseases. These diseases, such as Alzheimer's and Parkinson's, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and other abnormally formed neural structures.

Research has shown that LOC105369325 is involved in the development of neurodegenerative diseases, and that its levels are often decreased in the brains of individuals with these diseases. Additionally, studies have shown that LOC105369325 has been shown to protect against neurodegenerative diseases by increasing the levels of HSP70 in the brain.

Another potential use for LOC105369325 is as a biomarker for the diagnosis and monitoring of autoimmune disorders. These disorders, such as rheumatoid arthritis and multiple sclerosis, are characterized by the immune system attacking the body's own tissues.

Research has shown that LOC105369325 is involved in the development and progression of autoimmune disorders. For example, studies have shown that LOC105369325 is highly expressed in the tissues of individuals with rheumatoid arthritis, and that its levels are decreased in individuals with this disease.

In addition to its potential uses as a drug target and biomarker, LOC105369325 is also of interest as a potential research tool for studying the role of HSPs in various biological processes. The HSP family of proteins is known for their ability to interact with a wide variety of molecules, and research has shown that LOC105369325 plays a key role in many of these interactions.

Overall, LOC105369325 is a protein that is of great interest as a potential drug target and biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in stress response, inflammation, and the development of these diseases makes it a promising candidate for further study.

Protein Name: Uncharacterized LOC105369325

The "LOC105369325 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369325 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204